Table 5.

Univariate survival analysis: progression rate in low- and high-risk groups of sCr, proteinuric, and histologic parameters defined according to a cutoff with the highest sensitivity and specificity for progression (all patients independently from treatment)a

Risk FactorsProgressionP
sCr < versus ≥1.74 (20 versus 14)5 versus 71%<0.0001
FEIgG/SG < versus ≥0.00034 (22 versus 12)5 versus 83%<0.0001
FEα1m/SG < versus ≥0.04 (21 versus 13)5 versus 77%<0.0001
TID score < versus ≥3 (13 versus 21)0 versus 52%0.0059
GGS < versus ≥20% (18 versus 16)11 versus 56%0.0157
uα2m/g uCr/SG < versus ≥0.11 (24 versus 10)12 versus 80%0.0003
24hP/SG < versus ≥0.034 (24 versus 10)11 versus 56%0.0100
Cellular crescents < versus ≥17% (17 versus 17)24 versus 41%0.2580
  • a Numbers in parentheses are the number of patients of the low- and high-risk groups, respectively.